Click For Photo: https://cdn01.dailycaller.com/wp-content/uploads/2019/07/joni-ernst-e1562789592296.jpg
The Senate Judiciary Committee passed two bills targeting the high cost of drugs on June 27, and a committee member, Sen. Joni Ernst, spoke Wednesday with the Daily Caller News Foundation about what comes next.
“We really would like to see them done this year,” Ernst, an Iowa Republican who sponsored both bills, told the DCNF in an in-person interview. “This is something that shouldn’t be a political football. We need action soon, and people need relief, so people need to move on these bills.”
Ernst - Bills - Package - CREATES - Act
Ernst sees the two bills being incorporated into a package with the CREATES Act, a bipartisan bill that would prevent drugmakers from slowing down the development of generic alternatives. Ernst is also signed onto the CREATES Act, which was introduced during the last Congress and passed the Judiciary Committee on June 14.
The other bills in the package would include the Prescription Pricing for the People Act and Preserving Access to Cost Effective Drugs (PACED) Act, the two bills that passed the Judiciary Committee on June 27. The former is a bipartisan bill with a companion in the House that boasts the support of both Democratic New York Rep. Jerry Nadler and Republican North Carolina Rep. Mark Meadows.
Prescription - Pricing - People - Act - Federal
The Prescription Pricing for the People Act empowers the Federal Trade Commission to examine pharmacy benefit managers, which act as middlemen in the drug supply chain.
“Anytime I’m going through the state of Iowa, when I stop at an independent pharmacy, this is the big issue that our pharmacists have, is that these PBMs will come back, maybe a month or two later, and...
Wake Up To Breaking News!